Pharma Giants' $454M Glumetza Antitrust Deal Gets Initial OK
U.S. District Judge William Alsup preliminarily approved $454 million in settlements Wednesday resolving direct buyers' allegations that Bausch Health Cos. Inc., Lupin Pharmaceuticals Inc. and Assertio Therapeutics Inc. plotted to delay...To view the full article, register now.
Already a subscriber? Click here to view full article